10.1002/ejoc.201901178
European Journal of Organic Chemistry
FULL PAPER
from CEM) and a CEM DiscoverTM focused MW reactor (ν = 2.45 GHz) equipped
with a built–in pressure measurement sensor and a vertically focused IR
temperature sensor. Controlled temperature, power, and time settings were
used for all reactions. The NMR spectra were recorded on a Bruker Avance 400
(400.13 MHz for 1H; 100.61 MHz for 13C) at 298 K. The NMR spectroscopic data
were recorded in CDCl3 with the residual non–deuterated signal for 1H NMR
and the deuterated solvent signal for 13C NMR as internal standards. Melting
points were determined using a capillary melting point apparatus and are
uncorrected. The high-resolution mass spectra (HRMS) were obtained on an
Agilent Technologies Q−TOF 6520 spectrometer via electrospray ionization (ESI).
The mass spectrum of PHb−CN was recorded on a Thermo-Scientific LCQ
FleetTM ion-trap mass spectrometer using positive ion mode ESI and a direct
inlet system. The UV-vis absorption and fluorescence spectra were recorded at
room temperature (approximately 20 °C) on Varian Cary 100 and Cary Eclipse
spectrophotometers, respectively (both are Agilent Technologies devices) using
quartz cuvettes with a path length of 1 cm. For fluorescence measurements,
both the excitation and emission slit widths were 5 nm.
m, 3H), 1.74 (s, 6H), 3.93 (br s, 9H), 4.99 (br m, 2H), 6.87 (s, 2H), 7.32 (br m, 1H),
7.52–7.57 (br m, 4H), 7.91–8.00 (br m, 2H), 8.18–8.27 (br m, 2H), 8.60 (br s, 1H),
10.35 (s, 1H) ppm; 13C{1H} NMR (100 MHz, CDCl3): δ = 14.2 (CH3), 27.4 (CH3),
44.2 (CH2), 51.9 (C), 56.9 (CH3), 61.1 (CH3), 106.4 (CH), 112.0 (CH), 114.1 (CH),
114.3 (CH), 119.1 (C), 122.7 (CH), 123.3 (CH), 126.8 (C), 129.4 (CH), 129.8 (CH),
133.2 (CH), 139.1 (CH), 139.6 (C), 140.5 (C), 143.0 (C), 146.7 (CH), 149.1 (CH),
150.2 (C), 153.9 (C), 156.3 (C), 181.0 (C) ppm. HRMS (ESI+): calcd. For
C31H33N4O3+ 509.2547 [M – I ]+; found 509.2556.
(E)-1-Ethyl-3,3-dimethyl-2-(2-(3-(2-hydroxyphenyl)-1-(pyridin-2-yl)-1H-
pyrazol-4-yl)vinyl)-3H-indolium iodide (PHd): By following the general
procedure in the reaction with 3-(2-hydroxyphenyl)-1-(pyridin-2-yl)-1H-
pyrazole-4-carbaldehyde (1d, 133 mg, 0.5 mmol), the salt PHd was obtained as
a red solid (256 mg, 85%): Mp 145–146 °C. 1H NMR (400 MHz, CDCl3): δ = 1.50 (t,
J = 7.1 Hz, 3H), 1.71 (s, 6H), 2.09 (s, 3H), 4.80 (m, 2H), 7.31 (m, 2H), 7.43–7.59
(m, 7H), 7.68 (d, J = 15.9, 1H), 7.88 (t, J = 7.5 Hz, 1H), 8.14 (m, 2H), 8.57 (br s,
1H), 10.27 (s, 1H) ppm; 13C{1H} NMR (100 MHz, CDCl3): δ = 14.0 (CH3), 21.0
(CH3), 27.0 (CH3), 43.7 (CH2), 52.1 (C), 111.5 (CH), 113.5 (CH), 114.5 (CH), 119.6
(C), 122.7 (CH), 123.1 (CH), 123.5 (CH), 125.0 (C), 126.6 (CH), 129.5 (CH), 129.6
(CH), 131.1 (CH), 131.6 (CH), 139.0 (CH), 140.2 (C), 143.1 (C), 146.4 (CH), 148.7
(C), 148.9 (CH), 150.1 (C), 151.7 (C), 169.0 (C), 181.3 (C) ppm. HRMS (ESI+):
calcd. For C30H29N4O2+ 477.2285 [M – I]+; found 477.2289.
Synthesis and characterization of PHa–e and PHb–CN
The chemodosimeters PHa–e were synthesized in good yields (75–88%) by the
Knoevenagel reaction between the appropriate 4-formylpyrazole 1a–e and the
indolium salt 2 (Scheme 2). The detailed synthetic route of PHa–e starting from
freshly synthesized 2-hydrazinylpyridine (4)[20] and commercial acetophenones
3a–e is shown in the SI† (Scheme S1). The experimental results and structural
characterization data of the precursors 5a–c and 1a–c are consistent with our
recently reported data,[9] while the results for the novel precursors 5d–e and
1d–e are detailed in the SI†. The structures of PHa–e and precursors (1 and 5)
were elucidated by 1H and 13C NMR spectroscopy (Figs. S2–S11, SI†) and HRMS
analysis (Figs. S12–S22, SI†). Thermogravimetric analysis (TGA) of PHa–e
indicated that these salts exhibit high thermal stability and low solvent residues
(Figs. S1, SI†).
(E)-1-Ethyl-3,3-dimethyl-2-(2-(3-(4-hydroxyphenyl)-1-(pyridin-2-yl)-1H-
pyrazol-4-yl)vinyl)-3H-indolium iodide (PHe): By following the general
procedure in the reaction with 3-(4-hydroxyphenyl)-1-(pyridin-2-yl)-1H-
pyrazole-4-carbaldehyde (1e, 133 mg, 0.5 mmol), the salt PHe was obtained as
a red solid (266 mg, 88%): Mp 105–106 °C. 1H NMR (400 MHz, CDCl3): δ = 1.55 (t,
J = 7.3 Hz, 3H), 1.73 (s, 6H), 2.34 (s, 3H), 4.86 (m, 2H), 7.29 (m, 3H), 7.48–7.60
(m, 4H), 7.70 (d, J = 8.6, 2H), 7.18 (d, J = 16.2 Hz, 1H), 7.89 (d, J = 8.6 Hz, 1H),
8.20 (m, 2H), 8.54 (d, J = 4.8 Hz, 1H), 10.24 (s, 1H) ppm; 13C{1H} NMR (100 MHz,
CDCl3): δ = 14.2 (CH3), 21.2 (CH3), 27.2 (CH3), 44.0 (CH2), 51.9 (CH3), 111.8 (CH),
113.7 (CH), 114.4 (CH), 118.8 (C), 122.4 (CH), 122.7 (CH), 123.1 (CH), 128.9 (C),
129.5 (CH), 129.7 (CH), 130.1 (CH), 132.9 (CH), 139.1 (CH), 140.2 (CH), 142.9 (C),
146.1 (C), 148.9 (CH), 150.0 (C), 151.7 (CH), 154.9 (C), 169.3 (C), 180.9 (C) ppm.
HRMS (ESI+): calcd. For C30H29N4O2+ 477.2285 [M – I]+; found 477.2287.
General procedure for the synthesis of the Integrated pyrazole–hemicyanine
systems PHa–e: A mixture of 1a–e (0.50 mmol), freshly synthesized 1-ethyl-
2,3,3-trimethyl-3H-indol-1-ium iodide (2)[30] (2, 205 mg, 0.65 mmol) and sodium
acetate (53 mg, 0.65 mmol) in acetic anhydride (2.0 mL) was refluxed for 3 h.
Subsequently, the reaction was allowed to cool to room temperature and was
concentrated under reduced pressure, and the solid residue was directly
purified by flash chromatography on silica gel (eluent, CH2Cl2) to afford the pure
products PHa–e in good yields as red-orange solids.
Synthesis of (E)-1-ethyl-2-(2-(3-(4-methoxyphenyl)-1-(pyridin-2-yl)-1H-pyrazol-
4-yl)vinyl)-3,3-dimethylindoline-2-carbonitrile (PHb–CN): A solution containing
PHb (100 mg, 0.173 mmol) and NaCN (15 mg, 0.306 mmol) in ethanol:water
(10:1 v/v) was stirred at 20 °C for 10 min. The product was extracted with DCM
and the organic phase was concentrated under reduced pressure to afford the
pure product PHb–CN (81 mg, 98%) as a yellow solid. Mp 120–121 °C. 1H NMR
(400 MHz, CDCl3): δ = 1.18 (t, 3H), 1.31 (t, J = 7.2, 3H), 1.51 (s, 3H), 3.20 (m, 2H),
3.86 (s, 3H), 6.11 (d, J = 16.2, 1H), 6.62 (d, J = 7.6, 1H), 6.83 (d, J = 7.7 Hz, 1H),
7.00–7.25 (m, 6H), 7.66 (d, J = 8.7, 2H), 7.80 (t, J = 7.3, 1H), 8.08 (t, J = 8.1, 1H),
8.42 (d, J = 4.0, 1H), 8.77 (s, 1H) ppm; 13C{1H} NMR (100 MHz, CDCl3): δ = 14.6
(CH3), 23.2 (CH3), 24.3 (CH3), 41.0 (CH2), 49.2 (C), 55.3 (CH3), 79.8 (C), 108.2 (CH),
112.6 (CH), 114.3 (CH), 118.3 (C), 118.4 (C), 119.7 (CH), 121.6 (CH), 121.8 (CH),
123.6 (CH), 124.9 (C), 125.2 (CH), 125.8 (CH), 128.2 (CH), 129.6 (CH), 136.3 (C),
138.2 (C), 148.0 (CH), 151.1 (C), 152.5 (C), 160.0 (C) ppm. MS (ESI) m/z = 476.25
(MH+, 10%) and 449.28 (MH+ – HCN, 100%); m/z calcd. (C30H30N5O+) = 476.24
[MH]+ and 449.23 [M – HCN]+ (Figs. S35 and S37, SI†).
(E)-1-Ethyl-3,3-dimethyl-2-(2-(3-phenyl-1-(pyridin-2-yl)-1H-pyrazol-4-yl)vinyl)-
3H-indolium iodide (PHa): By following the general procedure in the reaction
with 3-(phenyl)-1-(pyridin-2-yl)-1H-pyrazole-4-carbaldehyde (1a, 125 mg, 0.5
mmol), the salt PHa was obtained as an orange solid (205 mg, 75%): Mp 245–
244 °C. 1H NMR (400 MHz, CDCl3): δ = 1.59 (t, J = 7.1 Hz, 3H), 1.72 (s, 6H), 4.98
(m, 2H), 7.31 (t, J = 5.7 Hz, 1H), 7.49–7.57 (m, 7H), 7.68 (d, J = 7.0, 2H), 7.91 (t, J
= 7.0 Hz, 1H), 7.98 (d, J = 16.0 Hz, 1H), 8.20 (d, J = 16.0 Hz, 1H), 8.26 (d, J = 8.3
Hz, 1H), 8.60 (d, J = 4.1 Hz, 1H), 10.38 (s, 1H) ppm; 13C{1H} NMR (100 MHz,
CDCl3): δ = 14.2 (CH3), 27.4 (CH3), 44.1 (CH2), 51.9 (C), 111.8 (CH), 113.8 (CH),
114.5 (CH), 118.9 (C), 122.6 (CH), 123.1 (CH), 129.0 (CH), 129.1 (CH), 129.4 (CH),
129.6 (CH), 129.7 (CH), 131.3 (C), 132.8 (CH), 139.0 (CH), 140.3 (C), 142.9 (C),
146.5 (CH), 150.1 (C), 156.0 (C), 181.0 (C) ppm. HRMS (ESI+): calcd. For
C28H27N4+ 419.2236 [M – I]+; found 419.2244
Photophysical properties of salts PHa-e
(E)-1-Ethyl-3,3-dimethyl-2-(2-(3-(4-methoxyphenyl)-1-(pyridin-2-yl)-1H-
pyrazol-4-yl)vinyl)-3H-indolium iodide (PHb): By following the general
procedure in the reaction with 3-(4-methoxyphenyl)-1-(pyridin-2-yl)-1H-
pyrazole-4-carbaldehyde (1b, 140 mg, 0.5 mmol), the salt PHb was obtained as
a red solid (214 mg, 77%): Mp 160–161 °C. 1H NMR (400 MHz, CDCl3): δ = 1.59 (t,
J = 7.0 Hz, 3H), 1.73 (s, 6H), 3.91 (s, 3H), 4.98 (m, 2H), 7.09 (d, J = 8.4 Hz, 2H),
7.31 (t, J = 6.2 Hz, 1H), 7.51–7.64 (m, 6H), 7.90 (t, J = 7.5 Hz, 1H), 7.97 (d, J =
16.0 Hz, 1H), 8.20 (d, J = 16.0 Hz, 1H), 8.25 (d, J = 4.5 Hz, 1H), 8.59 (s, 1H), 10.33
(s, 1H) ppm; 13C{1H} NMR (100 MHz, CDCl3): δ = 14.2 (CH3), 27.4 (CH3), 44.0
(CH2), 51.8 (C), 55.5 (CH3), 111.6 (CH), 113.9 (CH), 114.3 (CH), 114.5 (CH), 119.0
(C), 122.6 (CH), 123.1 (CH), 123.6 (C), 129.3 (CH), 129.7 (CH), 130.4 (CH), 132.9
(CH), 139.0 (CH), 140.4 (C), 142.9 (C), 146.9 (CH), 149.0 (CH), 150.2 (C), 156.0 (C),
160.8 (C), 181.3 (C) ppm. HRMS (ESI+): calcd. For C29H29N4O+ 449.2336 [M – I]+;
found 449.2332.
UV-vis absorption and fluorescence studies: The solvatochromic studies of the
compounds PHa–e were carried out in 1.0 × 10-5 M solutions using different
solvents (Figs. S23–S27), such as toluene (PhMe), dichloromethane (DCM),
acetonitrile (ACN), dimethylsulfoxide (DMSO), ethanol (EtOH), and water (H2O).
Determination of quantum yields: The quantum yields were obtained (Table S1,
SI†) by using quinine sulfate (ϕF = 0.50 in H2SO4 0.5 M at 300 nm) as a
reference and calculated according to the equation[24,31]
where x and st indicate the sample and standard solution, respectively, ϕ is the
quantum yield, F is the integrated area of the emission, A is the absorbance at
the excitation wavelength, and η is the refraction index of solvents.
(E)-1-Ethyl-3,3-dimethyl-2-(2-(3-(3,4,5-trimethoxyphenyl)-1-(pyridin-2-yl)-1H-
pyrazol-4-yl)vinyl)-3H-indolium iodide (PHc): By following the general
procedure in the reaction with 3-(3,4,5-trimethoxyphenyl)-1-(pyridin-2-yl)-1H-
pyrazole-4-carbaldehyde (1c, 170 mg, 0.5 mmol), the salt PHc was obtained as a
red solid (264 mg, 83%): Mp 150–151 °C. 1H NMR (400 MHz, CDCl3): δ = 1.61 (br
Design of the PHa–e Chemosensors
Response detection of PHa–e: The solutions of probes PHa–e (4.0 × 10-5 M)
were prepared in ethanol-water (99:1, v/v at pH = 7.05, 20 °C). The salts used in
This article is protected by copyright. All rights reserved.